Cohort Studies and Databases The Cohorts and Databases Core (CDC) will maintain two cohorts of patients and their associated databases and continually update and add information. In addition, the Core will maintain a database supporting tissue storage and use. The two populations of patients are men and women with breast cancer or women at increased risk because of genetic or histologic risk factors. Tissues are those blood samples and breast specimens kept in repositories at the DFCI, B VH or MGH. The databases are called CRIS (C'linical Research Information System), REACH (Risk Evaluation And Cancer History), and STIP (Specimen Tracking and Inventory Program). Men and women with breast cancer are prospcctively enteied into CRIS from the Gillette Breast Oncology Clinic at the DFCI and the AVON Breast Evaluation Center at the MGH. Women at high risk for breast cancer arc entered into REACH at the risk evaluation clinics at the DFCI and B1DMC. Data managers at the DFCI and MGH prospectively enter data into both registries. Users in the tissue banks at the DFCI, BWH and MGH use STIP for entry and inventory purposes. Reports are issued by specialized software to requesting investigators and down loaded to other registries. All three databases are kept on Partners HealthCare Information Systems'central computer facilities, and available on workstations throughout the Partners System. The Core will provide reports to SPORE investigators who have approved projects and after consultation about data requirements. The Core is also available to collaborators who are members of the DF/HCC or other investigators on a case-by-case basis. The Core will participate in the Core Coordinating Committee and will abide by policies and procedures agreed upon by the Committee.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA089393-10
Application #
7927073
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
10
Fiscal Year
2009
Total Cost
$162,630
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Kabraji, Sheheryar; Ni, Jing; Lin, Nancy U et al. (2018) Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? Clin Cancer Res 24:1795-1804
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Liu, Hui; Murphy, Charles J; Karreth, Florian A et al. (2018) Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer. Cancer Discov 8:354-369
Asdourian, Maria S; Swaroop, Meyha N; Sayegh, Hoda E et al. (2017) Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. J Clin Oncol 35:3934-3941
Sun, Fangdi; Skolny, Melissa N; Swaroop, Meyha N et al. (2016) The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat 157:229-240
Ferguson, Chantal M; Swaroop, Meyha N; Horick, Nora et al. (2016) Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer. J Clin Oncol 34:691-8
Miller, Cynthia L; Colwell, Amy S; Horick, Nora et al. (2016) Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study. Ann Surg 263:399-405
Sherr, Charles J; Beach, David; Shapiro, Geoffrey I (2016) Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov 6:353-67
Asdourian, Maria S; Skolny, Melissa N; Brunelle, Cheryl et al. (2016) Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol 17:e392-405
Kochupurakkal, Bose S; Iglehart, J Dirk (2016) Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA. Genom Data 7:92-3

Showing the most recent 10 out of 291 publications